Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIIC subunit 4 (GTF3C4) is a protein component of the transcription factor IIIC (TFIIIC) complex, which is essential for the transcription initiation of small RNA genes by RNA polymerase III, such as 5S rRNA and tRNA genes[2][6][7][10]. GTF3C4 functions as a DNA-binding subunit and possesses histone acetyltransferase activity, specifically acetylating histone H3 at lysine 14 (H3K14), suggesting a role in chromatin remodeling and gene activation[2][9][10]. It interacts with other TFIIIC subunits (such as GTF3C1, GTF3C2, GTF3C5) and with components of RNA polymerase III machinery, facilitating the assembly of the transcription machinery at Pol III promoters[2][5][10]. Mutations or altered expression of GTF3C4 have been linked to several diseases, including certain cancers and psoriasis, but it is not currently considered a typical therapeutic target or druggable protein[2][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIIC subunit 4 (GTF3C4).